Диссертация (1144259), страница 25
Текст из файла (страница 25)
-- Oct-Nov 1. -- T. 56, № 3-4. -- C. 319-29.[102] Khoshnan A., Ko J., Patterson P. H. Effects of intracellular expression of antihuntingtin antibodies of various specificities on mutant huntingtin aggregation andtoxicity // Proc Natl Acad Sci U S A. -- 2002. -- Jan 22. -- T. 99, № 2. -- C.
1002-7.- 134 -[103] Wolfgang W. J., Miller T. W., Webster J. M., Huston J. S., Thompson L. M.,Marsh J. L., Messer A. Suppression of Huntington's disease pathology in Drosophila byhuman single-chain Fv antibodies // Proc Natl Acad Sci U S A. -- 2005. -- Aug 9. -- T.102, № 32. -- C. 11563-8.[104] Thompson L. M., Aiken C.
T., Kaltenbach L. S., Agrawal N., Illes K., KhoshnanA., Martinez-Vincente M., Arrasate M., O'Rourke J. G., Khashwji H., Lukacsovich T.,Zhu Y. Z., Lau A. L., Massey A., Hayden M. R., Zeitlin S. O., Finkbeiner S., Green K.N., LaFerla F. M., Bates G., Huang L., Patterson P. H., Lo D. C., Cuervo A. M., MarshJ. L., Steffan J.
S. IKK phosphorylates Huntingtin and targets it for degradation by theproteasome and lysosome // J Cell Biol. -- 2009. -- Dec 28. -- T. 187, № 7. -- C. 108399.[105] Aiken C. T., Steffan J. S., Guerrero C. M., Khashwji H., Lukacsovich T.,Simmons D., Purcell J. M., Menhaji K., Zhu Y. Z., Green K., Laferla F., Huang L.,Thompson L. M., Marsh J.
L. Phosphorylation of threonine 3: implications forHuntingtin aggregation and neurotoxicity // J Biol Chem. -- 2009. -- Oct 23. -- T. 284,№ 43. -- C. 29427-36.[106] Atwal R. S., Desmond C. R., Caron N., Maiuri T., Xia J., Sipione S., Truant R.Kinase inhibitors modulate huntingtin cell localization and toxicity // Nat Chem Biol. -2011. -- May 29. -- T. 7, № 7. -- C. 453-60.[107] Steffan J. S., Agrawal N., Pallos J., Rockabrand E., Trotman L. C., Slepko N.,Illes K., Lukacsovich T., Zhu Y.
Z., Cattaneo E., Pandolfi P. P., Thompson L. M.,Marsh J. L. SUMO modification of Huntingtin and Huntington's disease pathology //Science. -- 2004. -- Apr 2. -- T. 304, № 5667. -- C. 100-4.[108] Tam S., Spiess C., Auyeung W., Joachimiak L., Chen B., Poirier M. A., FrydmanJ. The chaperonin TRiC blocks a huntingtin sequence element that promotes theconformational switch to aggregation // Nat Struct Mol Biol. -- 2009.
-- Dec. -- T. 16, №12. -- C. 1279-85.[109] Liebman S. W., Meredith S. C. Protein folding: sticky N17 speeds huntingtin pileup // Nat Chem Biol. -- 2010. -- Jan. -- T. 6, № 1. -- C. 7-8.[110] Duennwald M. L., Jagadish S., Muchowski P. J., Lindquist S. Flanking sequencesprofoundly alter polyglutamine toxicity in yeast // Proc Natl Acad Sci U S A. -- 2006. -Jul 18. -- T. 103, № 29. -- C. 11045-50.[111] Thakur A. K., Jayaraman M., Mishra R., Thakur M., Chellgren V. M., Byeon I. J.,Anjum D. H., Kodali R., Creamer T. P., Conway J.
F., Gronenborn A. M., Wetzel R.Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complexaggregation mechanism // Nat Struct Mol Biol. -- 2009. -- Apr. -- T. 16, № 4. -- C. 3809.[112] Bhattacharyya A., Thakur A. K., Chellgren V. M., Thiagarajan G., Williams A.D., Chellgren B. W., Creamer T. P., Wetzel R. Oligoproline effects on polyglutamineconformation and aggregation // J Mol Biol. -- 2006. -- Jan 20. -- T. 355, № 3. -- C.524-35.[113] Darnell G., Orgel J. P., Pahl R., Meredith S. C. Flanking polyproline sequencesinhibit beta-sheet structure in polyglutamine segments by inducing PPII-like helixstructure // J Mol Biol.
-- 2007. -- Nov 30. -- T. 374, № 3. -- C. 688-704.- 135 -[114] Darnell G. D., Derryberry J., Kurutz J. W., Meredith S. C. Mechanism of cisinhibition of polyQ fibrillation by polyP: PPII oligomers and the hydrophobic effect //Biophys J. -- 2009. -- Oct 21. -- T. 97, № 8. -- C. 2295-305.[115] Lecerf J. M., Shirley T. L., Zhu Q., Kazantsev A., Amersdorfer P., Housman D.E., Messer A., Huston J. S. Human single-chain Fv intrabodies counteract in situhuntingtin aggregation in cellular models of Huntington's disease // Proc Natl Acad SciU S A. -- 2001.
-- Apr 10. -- T. 98, № 8. -- C. 4764-9.[116] Colby D. W., Chu Y., Cassady J. P., Duennwald M., Zazulak H., Webster J. M.,Messer A., Lindquist S., Ingram V. M., Wittrup K. D. Potent inhibition of huntingtinaggregation and cytotoxicity by a disulfide bond-free single-domain intracellularantibody // Proc Natl Acad Sci U S A. -- 2004. -- Dec 21. -- T. 101, № 51. -- C. 1761621.[117] Colby D. W., Garg P., Holden T., Chao G., Webster J. M., Messer A., Ingram V.M., Wittrup K. D. Development of a human light chain variable domain (V(L))intracellular antibody specific for the amino terminus of huntingtin via yeast surfacedisplay // J Mol Biol. -- 2004. -- Sep 17.
-- T. 342, № 3. -- C. 901-12.[118] Vagner J., Qu H., Hruby V. J. Peptidomimetics, a synthetic tool of drug discovery// Curr Opin Chem Biol. -- 2008. -- Jun. -- T. 12, № 3. -- C. 292-6.[119] Zuckermann R. N., Martin E. J., Spellmeyer D. C., Stauber G. B., Shoemaker K.R., Kerr J. M., Figliozzi G.
M., Goff D. A., Siani M. A., Simon R. J., et al. Discovery ofnanomolar ligands for 7-transmembrane G-protein-coupled receptors from a diverse N(substituted)glycine peptoid library // J Med Chem. -- 1994. -- Aug 19. -- T. 37, № 17. - C. 2678-85.[120] Thakkar A., Cohen A. S., Connolly M. D., Zuckermann R. N., Pei D. Highthroughput sequencing of peptoids and peptide-peptoid hybrids by partial edmandegradation and mass spectrometry // J Comb Chem. -- 2009. -- Mar 9.
-- T. 11, № 2. -C. 294-302.[121] Yoo B., Kirshenbaum K. Peptoid architectures: elaboration, actuation, andapplication // Curr Opin Chem Biol. -- 2008. -- Dec. -- T. 12, № 6. -- C. 714-21.[122] Chen X., Wu J., Luo Y., Liang X., Supnet C., Kim M. W., Lotz G. P., Yang G.,Muchowski P. J., Kodadek T., Bezprozvanny I. Expanded polyglutamine-bindingpeptoid as a novel therapeutic agent for treatment of Huntington's disease // Chem Biol.-- 2011. -- Sep 23.
-- T. 18, № 9. -- C. 1113-25.[123] Luo Y., Vali S., Sun S., Chen X., Liang X., Drozhzhina T., Popugaeva E.,Bezprozvanny I. Abeta42-binding peptoids as amyloid aggregation inhibitors anddetection ligands // ACS Chem Neurosci. -- 2013. -- Jun 19. -- T. 4, № 6. -- C. 952-62.[124] Su T. P., London E. D., Jaffe J. H. Steroid binding at sigma receptors suggests alink between endocrine, nervous, and immune systems // Science. -- 1988. -- Apr 8. -T. 240, № 4849.
-- C. 219-21.[125] Gilbert P. E., Martin W. R. The effects of morphine and nalorphine-like drugs inthe nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog //J Pharmacol Exp Ther. -- 1976. -- Jul. -- T. 198, № 1. -- C. 66-82.[126] Su T. P. Evidence for sigma opioid receptor: binding of [3H]SKF-10047 toetorphine-inaccessible sites in guinea-pig brain // J Pharmacol Exp Ther.
-- 1982. -Nov. -- T. 223, № 2. -- C. 284-90.- 136 -[127] Snyder S. H., Largent B. L. Receptor mechanisms in antipsychotic drug action:focus on sigma receptors // J Neuropsychiatry Clin Neurosci. -- 1989. -- Winter. -- T. 1,№ 1. -- C. 7-15.[128] Hayashi T., Su T. P. Sigma-1 receptor chaperones at the ER-mitochondrioninterface regulate Ca(2+) signaling and cell survival // Cell. -- 2007. -- Nov 2. -- T. 131,№ 3.
-- C. 596-610.[129] Weng T. Y., Tsai S. A., Su T. P. Roles of sigma-1 receptors on mitochondrialfunctions relevant to neurodegenerative diseases // J Biomed Sci. -- 2017. -- Sep 16. -T. 24, № 1. -- C. 74.[130] Brune S., Schepmann D., Klempnauer K. H., Marson D., Dal Col V., Laurini E.,Fermeglia M., Wunsch B., Pricl S. The sigma enigma: in vitro/in silico site-directedmutagenesis studies unveil sigma1 receptor ligand binding // Biochemistry. -- 2014. -May 13. -- T. 53, № 18. -- C. 2993-3003.[131] Moebius F.
F., Striessnig J., Glossmann H. The mysteries of sigma receptors: newfamily members reveal a role in cholesterol synthesis // Trends Pharmacol Sci. -- 1997.-- Mar. -- T. 18, № 3. -- C. 67-70.[132] Nguyen L., Lucke-Wold B. P., Mookerjee S. A., Cavendish J. Z., Robson M. J.,Scandinaro A.
L., Matsumoto R. R. Role of sigma-1 receptors in neurodegenerativediseases // J Pharmacol Sci. -- 2015. -- Jan. -- T. 127, № 1. -- C. 17-29.[133] Hayashi T., Su T. P. Sigma-1 receptor ligands: potential in the treatment ofneuropsychiatric disorders // CNS Drugs. -- 2004. -- T. 18, № 5. -- C. 269-84.[134] Kimura Y., Fujita Y., Shibata K., Mori M., Yamashita T. Sigma-1 receptorenhances neurite elongation of cerebellar granule neurons via TrkB signaling // PLoSOne. -- 2013. -- T. 8, № 10. -- C. e75760.[135] Sha S., Qu W. J., Li L., Lu Z.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
